Mona Kamal Saadeldin

Citée par

	Toutes	Depuis 2020
Citations	304	289
indice h	10	9
indice i10	10	9

20162017201820192020202120222023202420252 3 9 18 42 71 63 85 9

Accès public

Tout afficher

4 articles

1 article

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Amal Kamal Abdel-AzizAssociate Professor of Pharmacology & Toxicology, ASUAdresse e-mail validée de pharma.asu.edu.eg
Saverio MinucciEuropean Institute of Oncology and University of MilanAdresse e-mail validée de ieo.it
Ahmed A AbdellatifAmerican University in CairoAdresse e-mail validée de aucegypt.edu
Diana Guirguis SamiThe American University in CairoAdresse e-mail validée de aucegypt.edu
Mohamad MagedNile University, Faculty of BiotechnologyAdresse e-mail validée de nu.edu.eg
Mario VarasiIFOMAdresse e-mail validée de ifom.eu
Eman DoklaFaculty of Pharmacy, Ain Shams UniversityAdresse e-mail validée de pharma.asu.edu.eg
Shereen Saeid ElshaerProfessor of Biochemistry and Molecular BiologyAdresse e-mail validée de hu.edu.eg
Khaled Abouzidprofessor of pharmaceutical chemistryAdresse e-mail validée de pharma.asu.edu.eg
Sandra N MilikLecturer, Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams UniversityAdresse e-mail validée de pharma.asu.edu.eg
Hamdino Mohamed AttiaProfessor of Anatomy, Damietta Faculty of Medicine, Al-Azhar University, EgyptAdresse e-mail validée de domazhermedicine.edu.eg
Marwa Tawfik BadawyThe American University in CairoAdresse e-mail validée de aucegypt.edu
Ahmed Hamed Salem, PhD, FCPAbbvie, University of Minnesota, Ain Shams UniversityAdresse e-mail validée de umn.edu
Ashraf B. Abdel-NaimProfessor of Pharmacology and Toxicology, King Abdulaziz UniversityAdresse e-mail validée de kau.edu.sa
Samia Shoumannational cancer institute, cairo universityAdresse e-mail validée de nci.cu.edu.eg
Rania SiamAmerican University in CairoAdresse e-mail validée de aucegypt.edu
Asma AmlehProfessor of Developmental Biology, The American University in CairoAdresse e-mail validée de aucegypt.edu
Francesco BertoliniDirector, Division of Laboratory Hematology-Oncology, European Institute of OncologyAdresse e-mail validée de ieo.it
Stefania OrecchioniEuropean Institute of OncologyAdresse e-mail validée de ieo.it
Paolo D'AmicoNorthwestern UniversityAdresse e-mail validée de northwestern.edu

Suivre

Mona Kamal Saadeldin

Affiliation inconnue

Adresse e-mail validée de aucegypt.edu

Immunology Cancer therapeutics Drug resistance Diabetes Epigenetics


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
Anti-diabetic effects of fenugreek (*Trigonella foenum-graecum*): A comparison between oral and intraperitoneal administration - an animal study M E. Baset, T I. Ali, H Elshamy, A M. El Sadek, D G. Sami, M T. Badawy, ... International journal of functional nutrition 1 (1), 2, 2020	55	2020
Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis MK Saadeldin, AK Abdel-Aziz, A Abdellatif Medical hypotheses 146, 110365, 2021	48	2021
Serum sclerostin and irisin as predictive markers for atherosclerosis in Egyptian type II diabetic female patients: A case control study MK Saadeldin, SS Elshaer, IA Emara, M Maged, AK Abdel-Aziz PLoS One 13 (11), e0206761, 2018	43	2018
Effects of Turmeric (Curcuma longa) Extract in streptozocin‐induced diabetic model AA R Essa, AM El Sadek, ME Baset, MA Rawash, DG Sami, MT Badawy, ME Mansour ... Journal of Food Biochemistry, doi.org/10.1111/jfbc.12988, 2019	38*	2019
Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition AK Abdel-Aziz, I Pallavicini, E Ceccacci, G Meroni, MK Saadeldin, ... haematologica 105 (8), 2105, 2020	33*	2020
A critical review of chloroquine and hydroxychloroquine as potential adjuvant agents for treating people with cancer AK Abdel-Aziz, MK Saadeldin, AH Salem, SA Ibrahim, S Shouman, ... Future Pharmacology 2 (4), 431-443, 2022	17	2022
New genetic variants of LATS1 detected in urinary bladder and colon cancer MK Saadeldin, H Shawer, A Mostafa, NM Kassem, A Amleh, R Siam Frontiers in Genetics 5, 425, 2015	15	2015
Preclinical models of breast cancer: Two-way shuttles for immune checkpoint inhibitors from and to patient bedside AK Abdel-Aziz, MK Saadeldin, P D'Amico, S Orecchioni, F Bertolini, ... European Journal of Cancer 122, 22-41, 2019	13	2019
FLT3 inhibitors and novel therapeutic strategies to reverse AML resistance: An updated comprehensive review AK Abdel-Aziz, EME Dokla, MK Saadeldin Critical Reviews in Oncology/Hematology, 104139, 2023	10	2023
Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer EME Dokla, AK Abdel-Aziz, SN Milik, AH Mahmoud, MK Saadeldin, ... Bioorganic Chemistry 117, 105451, 2021	10	2021
Thermal stability of a mercuric reductase from the Red Sea Atlantis II hot brine environment as analyzed by site-directed mutagenesis M Maged, A El Hosseiny, MK Saadeldin, RK Aziz, E Ramadan Applied and Environmental Microbiology 85 (3), e02387-18, 2019	9	2019
Insights into the design of inhibitors of the EGFR family with anticancer activity overcoming resistance: A case of optimizing thieno [2, 3-d] pyrimidine-based EGFR inhibitors SN Milik, AK Abdel-Aziz, MM El-Hendawy, RI El-Gogary, MK Saadeldin, ... Journal of Molecular Structure 1259, 132724, 2022	8	2022
The pancancer overexpressed NFYCAntisense 1 controls cell cycle mitotic progression through in cis and in trans modes of action C Pandini, G Pagani, M Tassinari, E Vitale, E Bezzecchi, MK Saadeldin, ... Cell Death & Disease 15 (3), 206, 2024	2	2024
Unleashing nature's potential and limitations: Exploring molecular targeted pathways and safe alternatives for the treatment of multiple sclerosis S Fathallah, A Abdellatif, MK Saadeldin Medicine international 3 (5), 1-13, 2023	2	2023
Highlights from the ‘Noncoding RNA world: From Mechanism to Therapy’conference, July 21-23, 2021 MK Saadeldin World Academy of Sciences Journal 3 (6), 1-5, 2021	1	2021
Deciphering the Complex Interplay of Long Noncoding RNAs and Aurora Kinases: Novel Insights into Breast Cancer Development and Therapeutic Strategies MK Saadeldin, G Curigliano, AK Abdel-Aziz Future Pharmacology 4 (3), 466-478, 2024		2024
Goat PRP14 (gPRP14) has xeno-antigenic properties and works as a vaccine in preclinical models of cancer S Minucci, B Bussolati, PE Massa, A Brossa, R Ravasio, M Saadeldin, ... bioRxiv, 2022.07. 04.498594, 2022		2022
Functional Study of the Noncoding Regulome of the Nuclear Factor Y G Pagani, C Pandini, MK Saadeldin, M Tassinari, E Bezzecchi, M Chiara, ...		2022
NFYC-AS1 antisense lncRNA as a potential novel player in cell cycle regulation in human cancer C Pandini, G Pagani, M Saadeldin, M Tassinari, E Bezzecchi, M Chiara, ...		2021
Molecular variation of the tumor suppressor gene LATS1 in urinary bladder cancer and colon cancer in Egyptian patients MKSA Saadeldin American University in Cairo, 2013		2013

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs